In the battle against antimicrobial resistance (AMR), India faces significant hurdles due to overwhelming antibiotic misuse and high infection rates. With these challenges, there’s a pressing need for strategic initiatives to optimize antibiotic use. Antimicrobial Stewardship Programs (ASPs) have emerged as a vital component in this fight, promising both economic and health benefits. This study delves into the cost-effectiveness of ASPs in India’s tertiary care settings, unveiling strategies that can dramatically reduce healthcare expenses and mortality rates.
Analytical Methodology
A comprehensive cost-effectiveness analysis was undertaken using a Markov model, contrasting scenarios with and without ASPs in Indian tertiary care hospitals. The research simulated outcomes for 1,000 hospitalized patients, tracking daily transitions through various health states, including the onset of resistant or sensitive infections, ICU admissions, recoveries, and deaths. This data-driven approach was fortified by insights from published works, hospital records, and expert consultations. Key health and financial outcomes—such as hospital days saved, deaths averted, and DALYs (Disability-Adjusted Life Years) reduced—were thoroughly examined.
Vital Findings
The adoption of ASPs witnessed a transformative 72% decrease in total care costs, from a substantial a122.07.09 million ($267,263.34) in hospitals without ASPs to a16.29 million ($74,998.06) with ASPs. Additionally, hospitals saw a dramatic reduction in patient stays—by 677 days in the general ward, 187 days in ICUs, and 865 days overall. Mortality rates also dropped, with 4.9 lives saved, representing a 5.3% reduction. The incremental cost-effectiveness ratios were notably negative, affirming ASPs as both cost-efficient and clinically superior.
Key inferences from the analysis include:
- A significant cost-saving advantage with ASP implementation.
- Reduced ICU and hospital durations demonstrate optimized resource utilization.
- Meaningful reductions in mortality highlight ASPs’ clinical efficacy.
The introduction of Antimicrobial Stewardship Programs in India’s tertiary care facilities presents a profound opportunity to combat antibiotic misuse effectively. Not only do ASPs translate into remarkable financial savings, but they also ensure significant enhancements in patient health outcomes. As India grapples with AMR, the financial and clinical benefits of ASP implementation cannot be overstated. Consequently, healthcare policymakers and hospital administrators should consider ASPs a cornerstone in the strategic management of antimicrobial practices. Their adoption promises sustainable progress toward defeating AMR, offering a robust framework that can be adapted to various healthcare settings across the nation.
This article has been prepared with the assistance of AI and reviewed by an editor. For more details, please refer to our Terms and Conditions. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author.
